Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
12/2012
12/11/2012US8329689 Substituted indoles and a method for the production and use thereof
12/11/2012US8329687 Pyridooxazepine derivative and use thereof
12/06/2012WO2012166390A1 Neprilysin inhibitors
12/06/2012WO2012163790A1 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
12/06/2012US20120309964 Cyclic amine compound and acaricide
12/06/2012US20120309960 Macrocycles as factor xia inhibitors
12/06/2012US20120309724 Neprilysin inhibitors
12/06/2012US20120306727 Fused polycyclic compound and organic light-emitting device using the compound
12/06/2012CA2835220A1 Neprilysin inhibitors
12/06/2012CA2833813A1 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
12/05/2012EP2530071A1 Fused polycyclic compound and organic light-emitting device using the compound
12/05/2012EP2528910A1 5-alkynyl pyrimidines and their use as kinase inhibitors
12/05/2012EP2528906A2 Process for the preparation of temsirolimus and its intermediates
12/05/2012EP2528896A1 Synthetic intermediate of oxazole compound and method for producing the same
12/05/2012CN102812005A Inhibitors of beta-secretase
12/05/2012CN102807571A Method used for preparing temsirolimus and suitable for industrial production
12/05/2012CN102807543A Reagent and method for detecting biological endogenous oxidants
12/05/2012CN102807509A Fused polycyclic compound and organic light-emitting device using the compound
12/05/2012CN101379055B Substituted quinolones III
12/04/2012US8324387 Substituted Oxazolo[5,4-b]pyridines
12/04/2012US8324254 Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists
12/04/2012US8324201 Pyrazinooxazepine derivatives
12/04/2012CA2694401C Polycyclic compound
12/04/2012CA2561313C Methods for minimizing thioamide impurities
11/2012
11/29/2012WO2012162129A1 Novel compounds as diacylglycerol acyltransferase inhibitors
11/29/2012WO2012161622A2 Incretin hormone secretion stimulators, method for producing and using same
11/29/2012WO2011156897A3 Polymorphic forms of rifaximin
11/29/2012US20120302792 Process of making alpha-aminooxyketone/alpha-aminooxyaldehyde and alpha-hydroxyketone/alpha-hydroxyaldehyde compounds and a process making reaction products from cyclic alpha, beta-unsaturated ketone substrates and nitroso substrates
11/29/2012US20120302757 Synthetic intermediate of oxazole compound and method for producing the same
11/29/2012US20120302613 Novel antibiotics
11/29/2012US20120302576 Ampk modulators
11/29/2012US20120302549 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
11/29/2012CA2836669A1 Novel compounds as diacylglycerol acyltransferase inhibitors
11/28/2012EP2527400A1 Polylactic acid composition
11/28/2012EP2527328A1 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
11/28/2012EP2527315A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/28/2012EP2527007A1 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
11/28/2012EP2526092A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
11/28/2012CN102803260A Substituted polycyclic carbamoylpyridone derivative
11/28/2012CN102802731A Benzimidazole derivatives useful as TRPM8 channel modulators
11/28/2012CN102802730A Benzimidazole derivatives useful as TRPM8 channel modulators
11/28/2012CN102796115A Method for preparing temsirolimus
11/28/2012CN101855224B Equilibrative nucleoside transporter ENT1 inhibitors
11/28/2012CN101667626B Organic electroluminescent devices and metal complex compounds
11/28/2012CN101260114B Polymorphous forms of rifaximin, preparation and application thereof used in pharmaceutical preparation
11/27/2012US8318787 Prodrugs of (3,5-bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-C]oxazol-7A-yl)methanol and derivatives thereof
11/27/2012US8318763 Rifamycin derivatives
11/27/2012US8318731 Pyrrolopyrimidines
11/27/2012US8318722 Pyrazinooxazepine derivatives
11/27/2012CA2695742C Bicyclic amides for enhancing glutamatergic synaptic responses
11/27/2012CA2533377C Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
11/27/2012CA2525214C Macrocyclic quinazoline derivatives as antiproliferative agents
11/27/2012CA2449830C New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
11/22/2012WO2012156951A1 Polymorph of rifaximin and process for the preparation thereof
11/22/2012WO2012156693A1 Process
11/22/2012WO2012156533A1 New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby
11/22/2012WO2012155981A1 New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby
11/22/2012WO2012112440A3 Fluorescent potassium ion sensors
11/22/2012WO2012109605A8 Forms of rifaximin and uses thereof
11/22/2012US20120296088 Synthesis of udp-glucose: n-acylsphingosine glucosyl transferase inhibitors
11/22/2012US20120295946 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof
11/22/2012US20120295942 Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists
11/22/2012US20120295901 Novel substituted bicyclic triazole derivatives as gamma secretase modulators
11/22/2012US20120295899 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity
11/22/2012US20120295897 Spiro-oxindole compounds and their uses as therapeutic agents
11/22/2012US20120295181 Benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the same, electrolyte membrane for fuel cell including the same, and fuel cell using the same
11/22/2012CA2844765A1 Polymorph of rifaximin and process for the preparation thereof
11/22/2012CA2835237A1 Process
11/21/2012EP2524917A1 Fused pyridine derivatives
11/21/2012EP2523963A1 2,5-substituted oxazolopyrimidine derivatives
11/21/2012EP2523962A1 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
11/21/2012EP2523961A1 2,5,7-substituted oxazolopyrimidine derivatives
11/21/2012EP2523960A1 Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
11/21/2012EP2523959A1 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
11/21/2012EP2523958A1 Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
11/21/2012CN102791718A Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
11/21/2012CN102791717A Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
11/21/2012CN102791716A 2,5,7-substituted oxazolopyrimidine derivatives
11/21/2012CN102791708A Inhibitors of akt activity
11/21/2012CN102791687A Novel inhibitors of hepatitis C virus replication
11/21/2012CN102786534A Preparation method of everolimus
11/21/2012CN102786533A Helicene analogs and preparation method thereof
11/20/2012US8314251 Total synthesis of salinosporamide A and analogs thereof
11/20/2012US8314094 Benzoxazinone derivative
11/20/2012US8314093 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
11/20/2012US8314091 N-benzyl,N'-arylcarbonylpiperazine derivatives
11/20/2012US8314088 Pyrazinooxazepine derivatives
11/20/2012CA2549675C Oxazolidinone-quinolone hybrid antibiotics
11/20/2012CA2537559C Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
11/15/2012WO2012154679A1 Tricyclic pyrazole sulfonamide compounds and methods of making and using same
11/15/2012WO2012154678A1 Tricyclic sulfonamide compounds and methods of making and using same
11/15/2012WO2012154353A1 Macrocyclic triazine compounds for the treatment of hepatitis c
11/15/2012WO2012152741A1 Bicyclic (thio)carbonylamidines
11/15/2012US20120289536 Pharmaceutical Compositions Comprising Colloidal Silicon Dioxide
11/15/2012US20120289532 Method for the production of amorphous rifaximin
11/15/2012US20120289497 Fused pyridine derivatives
11/15/2012US20120289493 Fused heterocyclic compounds as ion channel modulators
11/15/2012CA2835209A1 Tricyclic pyrazole sulfonamide compounds and methods of making and using same
11/15/2012CA2835195A1 Tricyclic sulfonamide compounds and methods of making and using same
11/14/2012EP2522671A2 Modulators of 5-HT receptors and methods of use thereof
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 220